VLP Influenza Vaccine Market Report

China VLP Influenza Vaccine Industry Market Research Report 2023-2029

  • POSTDATE：Oct 14, 2023
  • PAGES：226
  • REPORT CODE：GMM1854769
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the VLP Influenza Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ARTES Biotechnology

    • POSVAX

    • VBI

    • Merck

    • Saiba Animal Health

    • Spybiotech

    • Novavax

    By Type:

    • Live-attenuated Vaccine

    • Inactivated Vaccine

    • Others

    • Toxoid Vaccine

    By Application:

    • Medical Institution

    • Government

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China VLP Influenza Vaccine Market Overview 2018-2029

    • 1.1 China VLP Influenza Vaccine Industry Development Overview

    • 1.2 China VLP Influenza Vaccine Industry Development History

    • 1.3 China VLP Influenza Vaccine Industry Market Size (2018-2029)

    • 1.4 China VLP Influenza Vaccine Market Analysis by Type from Production Side

      • 1.4.1 China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Live-attenuated Vaccine (2018-2029)

      • 1.4.2 China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Inactivated Vaccine (2018-2029)

      • 1.4.3 China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Toxoid Vaccine (2018-2029)

    • 1.5 China VLP Influenza Vaccine Market Analysis by Application from Consumption End

      • 1.5.1 China VLP Influenza Vaccine Sales Volume, Sales Value and Growth Rate of Medical Institution (2018-2029)

      • 1.5.2 China VLP Influenza Vaccine Sales Volume, Sales Value and Growth Rate of Government (2018-2029)

      • 1.5.3 China VLP Influenza Vaccine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China VLP Influenza Vaccine Market Analysis by Region

      • 1.6.1 North China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    Chapter 2 China VLP Influenza Vaccine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on VLP Influenza Vaccine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China VLP Influenza Vaccine Market Status and Competition Analysis in 2023

      • 2.2.3 China VLP Influenza Vaccine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China VLP Influenza Vaccine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on VLP Influenza Vaccine Industry Development

    Chapter 3 VLP Influenza VaccineIndustry Chain Analysis

    • 3.1 VLP Influenza Vaccine Industry Chain

    • 3.2 VLP Influenza Vaccine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the VLP Influenza Vaccine Market

    • 3.3 VLP Influenza Vaccine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the VLP Influenza Vaccine Market

    Chapter 4 China VLP Influenza Vaccine Market, by Type

    • 4.1 China VLP Influenza Vaccine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China VLP Influenza Vaccine Total Production Volume and Growth Rate from Production Side

    • 4.5 China VLP Influenza Vaccine Production Volume and Growth Rate, by Type

      • 4.5.1 China VLP Influenza Vaccine Production Volume and Growth Rate of Live-attenuated Vaccine

      • 4.5.2 China VLP Influenza Vaccine Production Volume and Growth Rate of Inactivated Vaccine

      • 4.5.3 China VLP Influenza Vaccine Production Volume and Growth Rate of Others

      • 4.5.4 China VLP Influenza Vaccine Production Volume and Growth Rate of Toxoid Vaccine

    Chapter 5 China VLP Influenza Vaccine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China VLP Influenza Vaccine Total Market Size and Growth Rate from Consumption End

    • 5.5 China VLP Influenza Vaccine Market Size and Growth Rate, by Application

      • 5.5.1 China VLP Influenza Vaccine Market Size and Growth Rate of Medical Institution

      • 5.5.2 China VLP Influenza Vaccine Market Size and Growth Rate of Government

      • 5.5.3 China VLP Influenza Vaccine Market Size and Growth Rate of Others

    Chapter 6 China VLP Influenza Vaccine Market, by Region

    • 6.1 China VLP Influenza Vaccine Production Volume and Production Value, by Region

    • 6.2 China VLP Influenza Vaccine Sales Volume and Sales Value, by Region

    Chapter 7 North China VLP Influenza Vaccine Market Analysis

    • 7.1 North China VLP Influenza Vaccine Market, by Type

    • 7.2 North China VLP Influenza Vaccine Market, by Application

    Chapter 8 Central China VLP Influenza Vaccine Market Analysis

    • 8.1 Central China VLP Influenza Vaccine Market, by Type

    • 8.2 Central China VLP Influenza Vaccine Market, by Application

    Chapter 9 South China VLP Influenza Vaccine Market Analysis

    • 9.1 South China VLP Influenza Vaccine Market, by Type

    • 9.2 South China VLP Influenza Vaccine Market, by Application

    Chapter 10 East China VLP Influenza Vaccine Market Analysis

    • 10.1 East China VLP Influenza Vaccine Market, by Type

    • 10.2 East China VLP Influenza Vaccine Market, by Application

    Chapter 11 Northeast China VLP Influenza Vaccine Market Analysis

    • 11.1 Northeast China VLP Influenza Vaccine Market, by Type

    • 11.2 Northeast China VLP Influenza Vaccine Market, by Application

    Chapter 12 Southwest China VLP Influenza Vaccine Market Analysis

    • 12.1 Southwest China VLP Influenza Vaccine Market, by Type

    • 12.2 Southwest China VLP Influenza Vaccine Market, by Application

    Chapter 13 Northwest China VLP Influenza Vaccine Market Analysis

    • 13.1 Northwest China VLP Influenza Vaccine Market, by Type

    • 13.2 Northwest China VLP Influenza Vaccine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ARTES Biotechnology

        • 14.1.1 ARTES Biotechnology Company Profile

        • 14.1.2 ARTES Biotechnology VLP Influenza Vaccine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 POSVAX

        • 14.2.1 POSVAX Company Profile

        • 14.2.2 POSVAX VLP Influenza Vaccine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 VBI

        • 14.3.1 VBI Company Profile

        • 14.3.2 VBI VLP Influenza Vaccine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck

        • 14.4.1 Merck Company Profile

        • 14.4.2 Merck VLP Influenza Vaccine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Saiba Animal Health

        • 14.5.1 Saiba Animal Health Company Profile

        • 14.5.2 Saiba Animal Health VLP Influenza Vaccine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Spybiotech

        • 14.6.1 Spybiotech Company Profile

        • 14.6.2 Spybiotech VLP Influenza Vaccine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novavax

        • 14.7.1 Novavax Company Profile

        • 14.7.2 Novavax VLP Influenza Vaccine Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 VLP Influenza Vaccine Industry Research Conclusions

    • 15.2 VLP Influenza Vaccine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China VLP Influenza Vaccine Industry Market Size (2018-2029)

    • Figure China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Live-attenuated Vaccine (2018-2029)

    • Figure China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Inactivated Vaccine (2018-2029)

    • Figure China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China VLP Influenza Vaccine Production Volume, Production Value and Growth Rate of Toxoid Vaccine (2018-2029)

    • Figure China VLP Influenza Vaccine Sales Volume, Sales Value and Growth Rate of Medical Institution (2018-2029)

    • Figure China VLP Influenza Vaccine Sales Volume, Sales Value and Growth Rate of Government (2018-2029)

    • Figure China VLP Influenza Vaccine Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Central China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure South China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure East China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China VLP Influenza Vaccine Market Size and Growth Rate from 2018-2029

    • Figure VLP Influenza Vaccine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China VLP Influenza Vaccine Market Share by Type in 2018

    • Figure China VLP Influenza Vaccine Market Share by Type in 2023

    • Figure China VLP Influenza Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China VLP Influenza Vaccine Production Volume and Growth Rate of Live-attenuated Vaccine (2018-2023)

    • Figure China VLP Influenza Vaccine Production Volume and Growth Rate of Inactivated Vaccine (2018-2023)

    • Figure China VLP Influenza Vaccine Production Volume and Growth Rate of Others (2018-2023)

    • Figure China VLP Influenza Vaccine Production Volume and Growth Rate of Toxoid Vaccine (2018-2023)

    • Figure China VLP Influenza Vaccine Market Share by Application in 2018

    • Figure China VLP Influenza Vaccine Market Share by Application in 2023

    • Figure China VLP Influenza Vaccine Total Market Size and Growth Rate from Consumption End

    • Figure China VLP Influenza Vaccine Market Size and Growth Rate of Medical Institution (2018-2023)

    • Figure China VLP Influenza Vaccine Market Size and Growth Rate of Government (2018-2023)

    • Figure China VLP Influenza Vaccine Market Size and Growth Rate of Others (2018-2023)

    • Table China VLP Influenza Vaccine Production Volume by Region (2018-2023)

    • Table China VLP Influenza Vaccine Production Volume Share by Region (2018-2023)

    • Figure China VLP Influenza Vaccine Production Volume Share by Region (2018-2023)

    • Table China VLP Influenza Vaccine Production Value by Region (2018-2023)

    • Table China VLP Influenza Vaccine Production Value Share by Region (2018-2023)

    • Figure China VLP Influenza Vaccine Production Value Share by Region (2018-2023)

    • Table China VLP Influenza Vaccine Sales Volume by Region (2018-2023)

    • Table China VLP Influenza Vaccine Sales Volume Share by Region (2018-2023)

    • Figure China VLP Influenza Vaccine Sales Volume Share by Region (2018-2023)

    • Table China VLP Influenza Vaccine Sales Value by Region (2018-2023)

    • Table China VLP Influenza Vaccine Sales Value Share by Region (2018-2023)

    • Figure China VLP Influenza Vaccine Sales Value Share by Region (2018-2023)

    • Table North China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table North China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure North China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table North China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table North China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure North China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table Central China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table Central China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure Central China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table Central China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table Central China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Central China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table South China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table South China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure South China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table South China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table South China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure South China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table East China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table East China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure East China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table East China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table East China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure East China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northeast China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table Northeast China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northeast China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table Northeast China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table Northeast China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table Southwest China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table Southwest China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure Southwest China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table Southwest China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table Southwest China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northwest China VLP Influenza Vaccine Production Volume by Type (2018-2023)

    • Table Northwest China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northwest China VLP Influenza Vaccine Production Volume Share by Type (2018-2023)

    • Table Northwest China VLP Influenza Vaccine Sales Volume by Application (2018-2023)

    • Table Northwest China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China VLP Influenza Vaccine Sales Volume Share by Application (2018-2023)

    • Table ARTES Biotechnology Company Profile

    • Table ARTES Biotechnology VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)

    • Table POSVAX Company Profile

    • Table POSVAX VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)

    • Table VBI Company Profile

    • Table VBI VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)

    • Table Saiba Animal Health Company Profile

    • Table Saiba Animal Health VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)

    • Table Spybiotech Company Profile

    • Table Spybiotech VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)

    • Table Novavax Company Profile

    • Table Novavax VLP Influenza Vaccine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US